Prevention and treatment of venous thromboembolism in the elderly patient

by Enrico Tincani, Mark A Crowther, Fabrizio Turrini, Domenico Prisco
Published 2007-07-01

Examining the Clinical Use of Hemochromatosis Genetic Testing

by Matthew B Lanktree, Bruce B Lanktree, Guillaume Paré, John S Waye, Bekim Sadikovic, Mark A Crowther
Published 2015-01-01

Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

by Kimberly Legault, Mark Blostein, Marc Carrier, Susan Kahn, Sam Schulman, Sudeep Shivakumar, Cynthia Wu, Mark A. Crowther
Published 2020-05-01

A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

by Kimberly Legault, Mark Blostein, Marc Carrier, Susan Khan, Sam Schulman, Sudeep Shivakumar, Cynthia Wu, Mark A. Crowther
Published 2020-04-01

Coronary Artery Calcification, Cardiovascular Events, and Death: A Prospective Cohort Study of Incident Patients on Hemodialysis

by Trevor J. Wilkieson, M. Omair Rahman, Azim S. Gangji, Maurice Voss, Alistair J. Ingram, Nischal Ranganath, Charlie H. Goldsmith, Cathy Z. Kotsamanes, Mark A. Crowther, Christian G. Rabbat, Catherine M. Clase
Published 2015-08-01

Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial.

by Menaka Pai, Neill K J Adhikari, Marlies Ostermann, Diane Heels-Ansdell, James D Douketis, Yoanna Skrobik, Ismael Qushmaq, Maureen Meade, Gordon Guyatt, William Geerts, Michael W Walsh, Mark A Crowther, Jan O Friedrich, Lisa Burry, Rinaldo Bellomo, Nilton Brandão da Silva, Rubens Costa Filho, Michael J Cox, Suzana Alves Silva, Deborah J Cook, PROTECT (Prophylaxis for Thromboembolism in Critical Care Trial) Investigators
Published 2018-01-01